Magnetar Financial’s NRX Pharmaceuticals NRXP Stock Holding History

Magnetar Financial’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,600	Closed	-$1.25M	–	840
2020 Q3	$1.25M	Sell	11,600 -6,900	-37%	-$743K	0.02%	311
2020 Q2	$1.94M	Hold	18,500	–	–	0.06%	161
2020 Q1	$1.91M	Sell	18,500 -28,000	-60%	-$3M	0.05%	146
2019 Q4	$4.93M	Hold	46,500	–	–	0.1%	122
2019 Q3	$4.89M	Buy	+46,500	New	+$4.87M	0.12%	108

Other funds holding NRXP

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Magnetar Financial's NRXP Position: Q4 2020 in Review

Magnetar Financial sold out of NRX Pharmaceuticals (NRXP) in Q4 2020, closing a stake of 11,600 shares — an estimated $1.25M sold.

Magnetar Financial first reported a position in NRXP in Q3 2019 and held it in 5 quarters. The position peaked at $4.93M in Q4 2019. 6 funds tracked by Wall St. Rank hold NRXP as of Q4 2020.

Magnetar Financial reported no remaining NRX Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Magnetar Financial sold 11,600 NRX Pharmaceuticals shares in Q4 2020, an estimated $1.25M.
Magnetar Financial first reported a position in NRX Pharmaceuticals in Q3 2019 and held it in 5 quarters.
Magnetar Financial's NRX Pharmaceuticals position peaked at $4.93M in Q4 2019.
6 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2020.

Based on Magnetar Financial's 13F filing for Q4 2020, filed 12 Feb 2021.